EAGLE PHARMACEUTICALS, INC. Quarterly Unrecognized Tax Benefits in USD from Q4 2015 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Eagle Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2015 to Q2 2023.
  • Eagle Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending June 30, 2023 was $0.000.
Unrecognized Tax Benefits, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $0 $0 Jun 30, 2023 10-Q/A 2023-08-09
Q1 2023 $0 $0 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $0 Dec 31, 2022 10-K 2023-03-23
Q3 2022 $0 $0 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $0 $0 Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $0 $0 Mar 31, 2022 10-Q 2022-05-09
Q3 2021 $0 $0 Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $0 $0 Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $0 $0 Mar 31, 2021 10-Q 2021-05-10
Q3 2020 $0 $0 Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $0 $0 Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $0 $0 Mar 31, 2020 10-Q 2020-05-11
Q3 2019 $0 $0 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $0 $0 Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $0 $0 Mar 31, 2019 10-Q 2019-05-07
Q3 2018 $0 $0 Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $0 $0 Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $0 $0 Mar 31, 2018 10-Q 2018-05-10
Q3 2017 $0 Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $0 Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $0 Mar 31, 2017 10-Q 2017-05-08
Q4 2015 $0 Dec 31, 2015 10-K 2016-02-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.